Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes.
about
Inhibitory effects of aprindine on the delayed rectifier K+ current and the muscarinic acetylcholine receptor-operated K+ current in guinea-pig atrial cellsInhibitory effect of 2,3-butanedione monoxime (BDM) on Na(+)/Ca(2+) exchange current in guinea-pig cardiac ventricular myocytesAntiarrhythmic drugs for out-of-hospital cardiac arrest with refractory ventricular fibrillationComparison of nifekalant and amiodarone for resuscitation of out-of-hospital cardiopulmonary arrest resulting from shock-resistant ventricular fibrillationD-Sotalol: death by the SWORD or deserving of further consideration for clinical use?Drug-induced ventricular tachyarrhythmia in isolated rabbit hearts with atrioventricular block.The effects of sotalol on ventricular repolarization during exerciseMS-551 and KCB-328, two class III drugs aggravated adrenaline-induced arrhythmias.Effects of tedisamil (KC-8857) on cardiac electrophysiology and ventricular fibrillation in the rabbit isolated heart.Nifekalant in the treatment of life-threatening ventricular tachyarrhythmiasA multicenter observational study of the effectiveness of antiarrhythmic agents in ventricular arrhythmias: A propensity-score adjusted analysis.Antiarrhythmic agents: current status and perspectives.Inhibitory effects of JTV-519, a novel cardioprotective drug, on potassium currents and experimental atrial fibrillation in guinea-pig heartsSD-3212, a new class I and IV antiarrhythmic drug: a potent inhibitor of the muscarinic acetylcholine-receptor-operated potassium current in guinea-pig atrial cells.Electrophysiologic effects of the IK1 inhibitor PA-6 are modulated by extracellular potassium in isolated guinea pig hearts.Efficacy of a pure Ikr blockade with nifekalant in refractory neonatal congenital junctional ectopic tachycardia and careful attention to damaging the atrioventricular conduction during the radiofrequency catheter ablation in infancy.Effects of class III antiarrhythmic drugs on the Na(+)-activated K+ channels in guinea-pig ventricular cells.IK independent class III actions of MS-551 compared with sematilide and dofetilide during reperfusion in anaesthetized rats.Reduction of repolarization reserve by halothane anaesthesia sensitizes the guinea-pig heart for drug-induced QT interval prolongation.Altered intracellular Ca2+ regulation in chronic rat heart failure.Effects of intravenous nifekalant, a class III antiarrhythmic drug, on atrial vulnerability parameters in patients with paroxysmal atrial fibrillation.Characterization of transient atrial rhythm occurring between typical atrial flutter and its termination with class III drugs.Effect of IKr blocker nifekalant on atrial action potential duration after successful internal cardioversion of chronic atrial fibrillation.Enhancing electrical cardioversion and preventing immediate reinitiation of hemodynamically deleterious atrial fibrillation with class III drug pretreatment.Effect of nifekalant for acute conversion of atrial flutter: the possible termination mechanism of typical atrial flutter.The anaesthetized rabbit with acute atrioventricular block provides a new model for detecting drug-induced Torsade de Pointes.Use of Intravenous Amiodarone in the Treatment of Nifekalant-Resistant Arrhythmia: A Review of 11 Consecutive Cases with Severe Heart Failure.
P2860
Q28343255-220399AB-95B1-43DF-93A4-7F92D93EFD5EQ28360209-41D13044-E585-4604-AC8E-8D889712AA6EQ30235184-7623F5BD-3104-4F04-AD56-3C76DEE446F7Q34021424-32F55C9B-0DE3-49B6-9794-7459DD88CAE7Q34074972-5CF054F9-669C-4841-B5AC-12E87FC8CA33Q34134389-4AFD8D67-5EB4-4D3E-91F3-9464F6186B2DQ34425081-369E3B32-0C8C-42C8-AFF1-A422CED3B301Q35027891-CA18B780-6AD6-462C-81F0-502E3FB7C4BFQ35873926-0A834EDC-11B6-4BCD-975B-4C46E4BDA025Q37902913-E304B5A9-9E67-4184-B8A2-B9235731811DQ39646654-CBB3F055-D461-435C-A2B3-7A8BD7C20A8DQ41581039-E757F9D0-622D-45C4-AC36-E025017750A7Q41844782-256B3BB7-5518-4421-B6DC-37A408DAE0FAQ41908675-43E24548-188F-4C61-9F19-55EE256B5FEEQ42032882-2A52B5ED-771D-4D14-850D-F5F7EE2C9278Q42205372-16C7D8B2-A2A9-4E75-940D-43AF22607B5CQ42232591-2E3A0495-B261-4D57-AE1D-9B14280443D5Q42580315-13DBBDA5-A7B6-4EEF-91E9-855C5C74C4C5Q43054873-46A8A480-0C1F-4536-8D74-3D102F8CE957Q43226825-A6E5C7EA-455D-4D23-AE8F-0FE471CEE280Q44756665-F83FE48B-ED5F-479D-933A-E543B7B9BD25Q46442766-738E2EF6-2D10-4FAC-83DB-B2BD744F9B36Q46470757-272756FA-E0FB-4C80-81E9-1FDD9C25348CQ46623755-F8892DE5-20DD-423A-973A-BBA94D6E7EB1Q46980852-EC11E5B5-365B-4FAC-A6C3-903CD346AB5FQ48088627-BD1451BF-C9B0-498C-A90C-5D3741450275Q55388953-B8726CCE-BD25-4A0D-BA9C-0B28EC9BAAFA
P2860
Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Effects of MS-551, a new class ...... n rabbit ventricular myocytes.
@ast
Effects of MS-551, a new class ...... n rabbit ventricular myocytes.
@en
type
label
Effects of MS-551, a new class ...... n rabbit ventricular myocytes.
@ast
Effects of MS-551, a new class ...... n rabbit ventricular myocytes.
@en
prefLabel
Effects of MS-551, a new class ...... n rabbit ventricular myocytes.
@ast
Effects of MS-551, a new class ...... n rabbit ventricular myocytes.
@en
P2093
P2860
P1476
Effects of MS-551, a new class ...... n rabbit ventricular myocytes.
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.1993.TB13546.X
P407
P577
1993-05-01T00:00:00Z